Antimicrobial Susceptibility and Synergy Studies of Burkholderia cepacia Complex Isolated from Patients with Cystic Fibrosis

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

Susceptibility (18 antimicrobial agents including high-dose tobramycin) and checkerboard synergy (23 combinations) studies were performed for 2,621 strains of Burkholderia cepacia complex isolated from 1,257 cystic fibrosis patients. Minocycline, meropenem, and ceftazidime were the most active, inhibiting 38%, 26%, and 23% of strains, respectively. Synergy was rarely noted (range, 1% to 15% of strains per antibiotic combination).

Knowledge Graph

Similar Paper

Antimicrobial Susceptibility and Synergy Studies of Burkholderia cepacia Complex Isolated from Patients with Cystic Fibrosis
Antimicrobial Agents and Chemotherapy 2007.0
Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis
Antimicrobial Agents and Chemotherapy 2010.0
Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
Antimicrobial Agents and Chemotherapy 2007.0
Time-Kill and Synergism Studies of Ceftobiprole against Enterococcus faecalis , Including β-Lactamase-Producing and Vancomycin-Resistant Isolates
Antimicrobial Agents and Chemotherapy 2007.0
Synthesis and synergistic antimycobacterial screening of chlorpromazine and its metabolites
Med. Chem. Commun. 2014.0
Tobramycin (Nebramycin Factor 6): In Vitro Activity Against <i>Pseudomonas aeruginosa</i>
Applied Microbiology 1971.0
In V itro Activity of the Aminoglycoside Antibiotic Arbekacin against Acinetobacter baumannii-calcoaceticus Isolated from War-Wounded Patients at Walter Reed Army Medical Center
Antimicrobial Agents and Chemotherapy 2010.0